Real-Time Monitoring of HL-1 Cell Viscoelasticity for Drug Cardiotoxicity Assessment using a Love Wave Biosensor
Junyu Zhang,Xinwei Wei,Yong Qiu,Weijie Yu,Yingying Xue,Yizhou Xiong,Shimeng Mou,Hangming Xiong,Yanjie Hu,Yong Zhou,Kejing Ying,Liujing Zhuang,Hao Wan,Ping Wang
DOI: https://doi.org/10.1149/1945-7111/ac29de
IF: 3.9
2021-10-01
Journal of The Electrochemical Society
Abstract:Recently, there is increasing interest in measuring the mechanical properties of cardiomyocytes for drug screening and drug evaluation, such as their contraction force and viscoelasticity. Conventional cardiac physiology experiments usually investigate cardiac function based on imaging and electrophysiology techniques. But it is difficult to quantitatively detect viscoelasticity of cell population. Therefore, an in vitro method for viscoelasticity detection of cardiomyocyte population is urgently needed. In this study, we used Love Wave biosensors to study the viscoelasticity of HL-1 cardiomyocyte population treated with doxorubicin hydrochloride (ADM). First, we optimized the cell density to maximize the cell viscoelastic changes and signal differences between different ADM doses. Then we monitored the viscoelasticity change of cardiomyocytes after ADM treatment. For the ADM dose of 0.1 μM, 1 μM, and 10 μM, we observed that the viscoelasticity of cells decreased with increasing ADM dose. Although HL-1 cardiomyocytes do not have the beating function, our results showed that they can still react to drug such as abnormal reproduction, shape adjustment, membrane properties change, and even detaching from the sensor surface. In addition, we demonstrated that the Love Wave biosensor is a potentially useful tool for early assessment of drug cardiotoxicity.
electrochemistry,materials science, coatings & films